The Maharashtra Food and Drug Administration (FDA) has cancelled licenses of 2,241 retail pharmacies and suspended licenses of another 1,857 retailers across the state for violation of Drugs & Cosmetics Act like dispensing medicines without prescription.
This is the follow-up of show cause notices issued by FDA to 4503 medical stores across the state between April 2014 and February 2015. During the year, the FDA had conducted inspections on 24,193 retail stores across the state.
The FDA's crackdown is in line with the fact that there is irrational usage of antibiotics and cancellation of licenses is done based on the non-compliance like dispensing medicines without prescription. This comes as a welcome change more so as cases of online sales of prescription drugs has come to light with the growing trends of self medication especially in in tier -1 cities across the country.
The Union health ministry had also amended the D&C Rules to insert Schedule H1 to regulate the use of antibiotics in the country, and had placed 46 antibiotics under this category.
Maharashtra FDA recently raided an e-commerce site Snapdeal’s office and subsequently filed FIR against the company’s directors at the Panvel police station in Raigad district for online sale of prescription drugs. The state regulator has also written to the Drug Controller General of India (DCGI) to take further action in the interest of patient safety.
The company was found contravening provisions of the D&C Act and the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. The offences under which the FIR have been registered and are cognizable and non-bailable.
The drugs included sildenafil citrate tablets, which are to be sold on prescription by urologists, psychiatrists, endocrinologists and dermatologists and also emergency contraceptives i-pill and Unwanted-72. Indiscriminate use of such drugs might lead to harmful effects.
The free availability of prescription drugs from online retail sites has added to the growing heap of questions on the lack of adequate regulatory framework for the e-tail sector. A senior FDA official explained, ''As per the Section 18 (c) of Drugs and Cosmetics Act, 1940 to be read with Rule 65, only a licensed retailer is entitled for the sale of drugs and that too on the basis of prescription of a doctor only."
Rule 65 prescribes the procedure to be adopted by the medical stores while selling the prescription drugs and under which the prescription from the registered medical practitioner is necessary for sale of Schedule H drugs under the Act.
The Maharashtra Food and Drug Administration (FDA) had cancelled licenses of 5,452 retail pharmacies and suspended licenses of another 3,178 retailers across the state in the year 2013-14 for violation of Drugs and Cosmetics Act. During the year, the FDA had conducted inspections on 48,086 retail stores in the state.
Similar kind of actions was also taken by FDA under the Drugs and Magic Remedies (Objectionable Advertisement) Act (DMR Act). FDA had served 1434 notices and filed 58 FIRs last year.